S Somanath, the head of the Indian Space Research Organisation (ISRO), has disclosed a recent diagnosis of stomach cancer. Speaking with Tarmak Media House, he revealed that the cancer was discovered concurrently with the launch of the Aditya-L1 mission in September of the previous year.
Somanath disclosed that there were initial health concerns during the Chandrayaan-3 mission launch, though the exact nature was unclear at the time.
Somanath confirmed that a growth was discovered during a routine scan on September 2, 2023, coinciding with the Aditya-L1 launch day
Following the scan revealing a growth in his stomach, Somanath underwent further tests in Chennai, which confirmed a hereditary disease, necessitating urgent medical intervention.
The ISRO chief underwent an operation and commenced chemotherapy to address the newly discovered health challenge alongside his professional commitments.
Somanath expressed gratitude for the unwavering support of his family and colleagues during this challenging period, indicating the impact on both personal and professional spheres.
Despite the initial shock, Somanath now views cancer treatment as a viable solution, reflecting his pragmatic approach towards confronting the disease head-on.
His resilience and unwavering spirit in the face of adversity have been evident throughout his journey, reflecting a remarkable strength of character.
Despite the health setback, Somanath has continued to fulfill his professional responsibilities as the head of ISRO, demonstrating his commitment to the organization's goals amidst personal adversity.